Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®

John O. Link, James G. Taylor, Alejandra Trejo‐Martin, Darryl Kato, Ashley A. Katana, Evan S. Krygowski, Zhengyu Yang, Sheila Zipfel, Jeromy J. Cottell, Elizabeth M. Bacon,

Bioorganic & Medicinal Chemistry Letters · 2019 · 31 citations · 20 references

DOIFull text

Open access

Concepts

References

20